Header Logo

Connection

Philip Liebson to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Philip Liebson has written about Dose-Response Relationship, Drug.
Philip Liebson
Connection Strength
0.075
Dose-Response Relationship, Drug
  1. Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.